Skip to main content
Lasque Tiarc

ROSEN, TRUSTED INVESTOR, Encourages bluebird bio

Vaseline 2 months ago

NEW YORK, April 21, 2024 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of bluebird bio, Inc. (NASDAQ: BLUE) between April 24, 2023 and December 8, 2023, both dates inclusive (the “Class Period”), at the important May 28, 2024, lead plaintiff deadline.

SO: If you purchased shares of Bluebird common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To enter the Bluebird class promotion, visit or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information about the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the court no later than May 28, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified advisors with a track record of success in leadership roles. Companies issuing notices often do not have comparable experience, resources or any meaningful recognition from peers. Many of these firms do not actually litigate securities class actions, but are merely intermediaries that refer clients or work with law firms that actually litigate the cases. Be wise when choosing counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone, the company managed to raise more than $438 million for investors. In 2020, founder Laurence Rosen was named Titan of Plaintiffs’ Bar by law360. Many of the firm’s lawyers are recognized by Lawdragon and Super Lawyers.

CASE DETAILS: According to the lawsuit, defendants made false and/or misleading statements. Specifically, Defendants created the false impression that: (1) Bluebird could obtain Federal Drug Administration (“FDA”) approval for lovo-cel, a gene therapy for sickle cell patients, without any black box warnings for hematological malignancies; (2) Bluebird would obtain a priority review voucher from the FDA and in turn sell it to strengthen Bluebird’s financial position for the lovo cell launch; (3) as a result, Bluebird significantly overestimated Lyfgenia’s clinical and/or commercial prospects; and (4) therefore, Bluebird’s public statements were materially false and misleading at all relevant times. When the real details emerged, the lawsuit alleged that investors suffered damages.

To enter the Bluebird class promotion, visit or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information about the class action.

No class is certified. Until a class is certified, you will not be represented by counsel unless you retain one. You can select a lawyer of your choice. You can also remain an absent class member and do nothing at this time. An investor’s ability to share in any future recovery is not contingent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: Twitter: or on Facebook:

Advertising lawyer. Previous results do not guarantee a comparable result.


Contact details:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, PA
275 Madison Avenue, 40th floor
New York, NY 10016
Phone: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]